Trials / Terminated
TerminatedNCT00514566
PDS vs Polyamide for Midline Abdominal Closure
Is Polydioxanone 'THE' Suture of Choice for Midline Abdominal Closure? Results of a Prospective Randomized Clinical Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Christian Medical College and Hospital, Ludhiana, India · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Within the last decade the customary trend of using non absorbable sutures has changed, with numerous studies and meta-analyses advocating the use of slowly absorbable sutures, claiming comparable wound strength with significantly lower incidence of wound complications. It was the objective of this randomized clinical trial to compare two universally accepted suture materials, the non-absorbable Nylon and the slowly absorbable Polydioxanone for midline abdominal closure in the Indian context.
Detailed description
64 patients undergoing midline laparotomy were allocated, using block randomization, to mass closure of the abdominal wall with continuous polyamide (34 patients) or continuous polydioxanone (30 patients). There was an alarmingly higher incidence of wound dehiscence in the PDS group requiring secondary suturing (Nylon 0; PDS 5). Mid-way through the trial, an interim analysis was performed which revealed an unacceptably high incidence of wound dehiscence in the PDS group. This necessitated a premature curtailment of the study. There was, however, a statistically significantly higher incidence of scar pain in the Nylon group (Nylon 9; PDS 1). There is a need for a study with larger series, and PDS as a choice of suture for midline wound closure cannot be recommended.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Suture for midline abdominal closure | closure with Polyamide or Polydioxanone |
Timeline
- Start date
- 2004-10-01
- Completion
- 2006-04-01
- First posted
- 2007-08-10
- Last updated
- 2007-08-10
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT00514566. Inclusion in this directory is not an endorsement.